Trials / Unknown
UnknownNCT04953936
β-hydroxy-β-methylbutyrate-enriched Nutritional Supplements for Obesity Adults
β-hydroxy-β-methylbutyrate-enriched Nutritional Supplements for Obesity Adults During Weight Loss: a Randomized Double-blind Placebo-controlled Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- West China Hospital · Academic / Other
- Sex
- All
- Age
- 30 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effectiveness and safety of HMB-enriched nutritional supplements for improving muscle mass and muscle function in Chinese adults with obesity during the weight loss process using calorie restriction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | HMB-enriched Nutritional Supplements | The participants will receive oral HMB-enriched nutritional supplements (65 g, once daily), which include soybean isolate protein, flaxseed oil powder, yam powder, whey protein, oligomeric isomaltose powder, cocoa powder, medium-chain fatty acid powder, calcium beta-hydroxy-beta-methylbutyrate, sunflower seed oil powder, L-glutamine, wheat germ powder, membrane isolated casein, wheat oligopeptide, konjac flour, vitamin E, vitamin D, stevioside, edible flavors. |
| DIETARY_SUPPLEMENT | Placebo | Placebo (maltodextrin 65 g once daily) with the same package as the intervention. |
| BEHAVIORAL | Caloric Restrition Diet | Caloric restriction diet with individualized nutritional guidance from professional dietitians by video regarding caloric restriction strategies |
Timeline
- Start date
- 2021-09-20
- Primary completion
- 2021-10-31
- Completion
- 2021-12-31
- First posted
- 2021-07-08
- Last updated
- 2021-09-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04953936. Inclusion in this directory is not an endorsement.